170372 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Amyloid plaque core protein
Method of Identifying Biomarkers of Neurological Diseases and Diagnosis of Neurological Diseases
#302Oligomer-specific amyloid beta epitope and antibodies
#303Heterocyclic molecules for biomedical imaging and therapeutic applications
#304Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβaggregates
#305Detection and removal of misfolded proteins/peptides
#306Pi-extended acedan derivatives, their application for two-photon microscopy imaging, and their application for two-photon microscopy imaging of amyloid-beta plaque in an alzheimer's disease animal model
#307Method for determination of amyloid peptides with anti-amyloid antibody
#308Antibody therapy for amyloid beta disease
#309Pharmaceutical composition for the treatment and/or prevention of disease involving abnormal accumulation of amyloid β protein
#310METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#311METHOD FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#312KINETICS BIOMARKERS FOR NEURODEGENERATION
#313Methods for detecting Aβ oligomers
#314HUMANIZED ANTIBODY IGG1
#315AFFINITY CAPTURE OF CIRCULATING BIOMARKERS
#316Method for detecting indicators for determining diseases
#317MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#318Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
#319METHODS FOR DIAGNOSING AND ASSESSING NEUROLOGICAL DISEASES
#320Gamma-Secretase Substrates and Methods of Use
#321Method of In Vitro Diagnosis of a Neurological Disorder
#322Diagnostic kit for diagnosis of abnormal protein aggregation- or misfolding-related diseases using dissociation of protein aggregates
#323System and method for early detection of alzheimers by detecting amyloid-beta using orbital angular momentum
#324Ultrasensitive assay for tau and methods of use thereof for assessing traumatic brain injury in tissues and biofluids
#325Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#326Detection of misfolded amyloid beta protein
#327METHODS FOR ANALYZING BLOOD TO DETECT DISEASES ASSOCIATED WITH ABNORMAL PROTEIN AGGREGATION
#328Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#329Uses of antibodies directed against amyloid-β
#330FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving Tau dysfunction
#331Composition and method for preventing or treating a tauopathy
#332Assay and method for identifying compounds that reduce SIL1 expression or activity
#333ASSAY FOR POLYPEPTIDE AGGREGATION USING MICRODROPLETS
#334Aβ protofibril binding antibodies
#335Polynucleotides encoding anti-amyloid beta monoclonal antibodies
#336IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#337Biomarkers and methods for measuring and monitoring inflammatory disease activity
#338Amyloid beta expression constructs and uses therefor
#339MR IMAGING DIAGNOSTIC AGENT FOR INTRACTABLE NEUROLOGICAL DISEASE
#340Antibodies that bind amyloid oligomers
#341NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
#342Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptides
#343Method for treating blood, blood products and organs
#344Method, composition, isolation and identification of a plaque particle and related biomarker
#345Antibodies, kit and method for detecting amyloid beta oligomers
#346Modular chemiresistive sensor
#347QUANTIFICATION OF TAU IN BIOLOGICAL SAMPLES BY IMMUNOAFFINITY ENRICHMENT AND MASS SPECTROMETRY
#348Methods and compositions for treating alzheimer's disease
#349Methods of treating a tauopathy
#350Methods for Diagnosing Mood Disorders
#351Modulation sAPP, sAAPα and BDNF levels in individuals diagnosed with FXS and ASD
#352DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#353Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#354BIOMARKERS FOR TANGLE-PREDOMINANT DEMENTIA
#355Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
#356METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#357MULTIPLEX AVIDITY PROFILING OF PROTEIN AGGREGATES
#358Polymers containing multivalent amyloid-beta-binding D-peptides and their use
#359Chronic Traumatic Encephalopathy in Blast-Exposed Individuals
#360Anti-sAPPβ antibody
#361Curcumin derivatives for amyloid-β plaque imaging
#362Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
#363Methods for Screening Inhibitors of Tau Phosphorylation By Casein Kinase I
#364Methods of treating a tauopathy
#365STANDARD FOR QUANTIFYING PATHOGENIC AGGREGATES FROM PROTEINS PRODUCED NATURALLY IN THE BODY
#366Water-soluble AIE luminogens for monitoring and retardation of fibrillation of amyloid proteins
#367Use of SAA1B/B homozygote in the prognosis and diagnosis of liver cirrhosis
#368METHOD FOR SELECTIVELY QUANTIFYING A-BETA AGGREGATES
#3692,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
#370METHODS OF DIAGNOSING TAU-ASSOCIATED NEURODEGENERATIVE DISEASES
#371PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#372METHOD FOR THE IDENTIFICATION OF BETA-SHEET AGGREGATED PROTEIN LIGANDS
#373BETA-AMYLOID IMAGING AGENTS, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF
#374Small molecules that covalently modify transthyretin
#375Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#376Methods of treating a tauopathy
#377Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
#378Diagnostic antibody assay
#379Method for diagnosing alzheimer's disease (AD)
#380Methods of treating a tauopathy
#381FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#382Detection and removal of misfolded proteins/peptides
#383Aβ-remover, Aβ-removing apparatus, and Aβ removal method
#384Diagnosis and treatment of Alzheimer's disease
#385Non-surgical method of treatment for cataract
#386Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)
#387Antibody, kit and method for determining amyloid peptides
#388Anti-idiotype antibody against an antibody against the amyloid β peptide
#389Anitbodies specific for the protofibril form of beta-amyloid protein
#390Biological complex specific for Alzheimer's disease detection in vitro and use thereof
#391Methods of treating neurodegenerative disease
#392Measurement of autoantibodies at low conductivity with increased sensitivity
#393Antibodies, kit and method for detecting amyloid beta oligomers
#394METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOOD
#395Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease
#396Diagnosis of alzheimer's disease using Aβ22(pE)-42 peptide
#397PHARMACEUTICAL COMPOSITION TO PREVENT AND TREAT ALZHEIMER'S DISEASE COMPRISING GCP II MUTANT
#398Oligomer-specific amyloid beta epitope and antibodies
#399Methods of treating diabetes and compositions capable of same
#400Amyloid Precursor Protein E2 Domain and Uses Thereof
#401NEW FORMULATIONS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
#402METHOD AND USE FOR ASSESSING RADIATION THERAPY IN ACCORDANCE WITH SAA
#403Method for diagnosing a protein misfolding disease using nerve cells derived from iPS cells
#404ASSAYS AND METHODS PERTAINING TO PRE-AMYLOID INTERMEDIATES
#405Peptides that specifically target amyloid deposits
#406Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#407METHODS FOR DIAGNOSING MOOD DISORDERS
#408IMMUNOASSAY STANDARDS AND MEASUREMENT OF CLINICAL BIOMARKERS USING INTRA-ASSAY CALIBRATION STANDARDS
#409FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#410NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIES
#411DETECTION AND TREATMENT OF TRAUMATIC BRAIN INJURY
#412Small molecules that covalently modify transthyretin
#413METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID BETA PEPTIDES
#414METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIES
#415Diagnostic antibody assay
#416Compounds for binding and imaging amyloid plaques and their use
#417Antibody recognizing turn structure in amyloid β
#418METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta
#419HUMAN SERUM AMYLOID-A3 ANTIBODY AND USE THEREOF
#420Methods and system for detecting soluble amyloid-β
#421Water-soluble AIE luminogen for monitoring and retardation of amyloid fibrillation of insulin
#422Anti-ADDL antibodies and uses thereof
#423Polynucleotides encoding an anti-beta-amyloid monoclonal antibody
#424AFFINITY CAPTURE OF CIRCULATING BIOMARKERS
#425Antibodies that specifically bind to A beta oligomers and use thereof
#426Antibodies that bind amyloid oligomers
#427Composition and method for treating a tauopathy
#428Method for quantifying phosphokinase activity on proteins
#429BLOOD PROTEIN MARKERS IN METHODS AND APPARATUSES TO AID DIAGNOSIS AND MANAGEMENT OF SLEEP DISORDERED BREATHING
#430Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
#431ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS
#432METHOD FOR DETECTING BETA-AMYLOID USING AMINO ACID DIMERS
#433METHOD FOR SCREENING INHIBITOR FOR INHIBITING INTERACTION BETWEEN BETA-AMYLOID PEPTIDE AND VEGF AND INHIBITOR SEARCHED BY THE SAME
#434Antibodies that specifically bind to A beta oligomers and use thereof
#435Protofibril selective antibodies and the use thereof
#436BIOMARKERS
#437Diagnostic antibody assay
#438Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#439Methods for identifying safe and functional humanized antibodies
#440Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#441METHOD FOR THE IN VITRO DIAGNOSIS OF AN AUTOIMMUNE RESPONSE ASSOCIATED WITH THE EXISTENCE OF AN ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES-ASSOCIATED VASCULITIS BY DETECTION OF ANTIBODIES DIRECTED AGAINST THE PENTRAXIN 3 ANTIGEN
#442Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
#443Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#444Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#445Monoclonal antibodies against amyloid beta protein and uses thereof
#446Optical method for detecting Alzheimer's disease by systemic administration of curcumin
#447Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
#448AB-REMOVER, AB-REMOVING APPARATUS, AND AB REMOVAL METHOD
#449INHIBITORS OF AMYLOID FIBRIL FORMATION AND USES THEREOF
#450ALZHEIMER'S DISEASE BIOMARKERS
#451Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#452GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#453Complex of a chaperone with β-amyloid and methods employing this complex
#454Method for Detecting Soluble Amyloid Precursor Protein (APP) Alpha and/or Soluble APP Beta
#455METHOD FOR TESTING ALZHEIMER'S DISEASE BY MEASURING DEGRADATION RATE OF ß-AMYLOID IN BLOOD AND DIAGNOSTIC REAGENT
#456Curcumin Derivatives for Amyloid-Beta Plaque Imaging
#457MONOCLONAL ANTIBODIES SPECIFIC FOR PATHOLOGICAL AMYLOID AGGREGATES COMMON TO AMYLOIDS FORMED FROM PROTEINS OF DIFFERING SEQUENCE
#458ASSAY FOR PATHOGENIC CONFORMERS
#459Protein Aggregation Domains and Methods of Use Thereof
#460METHOD AND SYSTEM FOR EMITTING LIGHT
#461Ligands for aggregated tau molecules
#462Methods and compositions for treating alzheimer's disease
#463Method for quantifying phosphokinase activity on proteins
#464Anti-ADDL antibodies and uses thereof
#465GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#466Isolsted Monoclonal - Associated Protein Tau and Kit
#467Biomarkers and methods for measuring and monitoring inflammatory disease activity
#468Alzheimer's diagnosis
#469METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION
#470ABeta-OLIGOMER MEASUREMENT METHOD
#471METHOD OF UPREGULATING SORLA FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#472Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof
#4732,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
#474Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
#475NOVEL ASSAY
#476Monoclonal Antibody
#477Compositions and methods for alzheimer's disease
#478Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#479BIOASSAY FOR YOKUKANSAN
#480SCREENING METHODS FOR AMYLOID BETA MODULATORS
#481TAU PROTEIN SCREENING ASSAY
#482Compositions and methods for detection and isolation of phosphorylated molecules
#483Histidine related compounds for identifying and blocking amyloid beta ion channels
#484PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES
#485PHENOTYPIC RATIO OF SERUM AMYLOID IN PRE- AND TYPE 2 DIABETES
#486Monoclonal antibody and use thereof
#487CLASSIFYING AMYLOIDOSIS
#488Monoclonal antibody
#489Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
#490γ-Secretase substrates and methods of use
#491Imaging agents for protein misfolding
#492Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
#493Anti-ADDL antibodies and uses thereof
#494Human anti-amyloid beta peptide antibody and fragment of said antibody
#495USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME
#496METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta
#497ASSAY FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE RATIO OF GAMMA-SECRETASE ABETA CLEAVAGE PRODUCTS
#498Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#499Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#500Antibodies specific for the protofibril form of beta-amyloid protein
#501AMYLOID BETA(1-42) OLIGOMERS, DERIVATIVES THEREOF AND ANTIBODIES THERETO, METHODS OF PREPARATION THEREOF AND USE THEREOF
#502Structure-based design of peptide inhibitors of amyloid fibrillation
#503Method of Screening Compounds Having Anti-Amyloid Properties
#504CDKI Pathway inhibitors and uses thereof to regulate expression to TAU protein
#505SCREENING ASSAYS FOR INHIBITORS OF BETA AMYLOID PEPTIDE ION CHANNEL FORMATION
#506Anti-idiotype antibody against an antibody against the amyloid β peptide
#507CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES THEREFOR
#508MODIFICATION OF AMYLOID-BETA LOAD IN NON-BRAIN TISSUE
#509Methods of Identifying Disease Biomarkers in the Lense of the Eye
#510Monoclonal antibodies that recognize epitopes of amyloid-beta
#511Means and methods for the production of amyloid oligomers
#512Detection and/or Characterisation of Oligomers
#513Degradation of prion protein and reduced prion infectivity by earthworm homogenates
#514Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#515Method for detecting aggregate-forming circulating protein forms using an agent for aggregating said forms and an agent for capturing formed aggregates
#516Method for Identiflying Modulators of Rufy2 Useful for Treating Alzheimer's Disease
#517Antibodies that specifically bind to Aβ oligomers and uses thereof
#518RECEPTOR FOR AMYLOID BETA AND USES THEREOF
#519Human brain carboxypeptidase B
#520Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
#521Fluorescent Analogs Of The Islet Amyloid Polypeptide
#522Compositions and methods for detection and isolation of phosphorylated molecules
#523Phosphorylation of tau by abl
#524USE OF PRION CONVERSION MODULATING AGENTS
#525NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#526Upregulation of Adamts4 Protease Activity for the Treatment of Alzheimer's Disease
#527Method for Testing Alzheimer's Disease by Measuring Degradation Rate of B-Amyloid in Blood and Diagnostic Reagent
#528Anti-ADDLs antibodies and uses thereof
#529Cell Model for Alzheimer's Disease Pathology
#530SERUM AMYLOID A PROTEIN IN INFLAMMATION AND OBESITY
#531Diagnostic Methods and Genetic Markers for Alzheimer Disease
#532Protofibril selective antibodies and the use thereof
#533Method of Differentially Diagnosing Dementias
#534Amyloid-beta globulomer antibodies
#535ALZHEIMER'S DISEASE ANIMAL MODEL, METHOD FOR OBTAINING SAME AND USES THEREOF
#536Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
#537ACOUSTIC WAVE TRANSDUCER SUBSTRATE AND MEASUREMENTS USING THE SAME
#538Methods for treating fibrosis using CRP antagonists
#539Methods for detecting the presence of mutant mammalian presenilin protein
#540Anti-Aβ globulomer 5F7 antibodies
#541Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease
#542CONFORMATIONAL ISOMERS OF ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS OF THEIR MANUFACTURE AND USE
#543Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
#544Angiogenic peptides and uses thereof
#545METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB
#546Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
#547Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
#548DETECTING SOLUBLE A-BETA
#549Low-Density Lipoprotein Receptor-Related Protein 2 Clears Amyloid-Beta Peptide A cross the Blood-Brain Barrier via Apolipoprotein J
#550HUMANIZED ANTIBODY IGG1
#551Isolated microtubule-associated protein tau peptides and kit
#552NOVEL BIOMARKERS FOR DIAGNOSIS AND/OR PROGNOSIS OF NEOPLASIAS IN ANIMALS
#553Method of Measuring Amyloid-Beta Peptides
#554Methods of screening for compounds that inhibit binding between amyloid-β(Aβ) and FC-γ receptor IIB (FcγRIIb)
#555Method for diagnosing alzheimer's disease
#556Method for quantifying phosphokinase activity on proteins
#557NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#558Assay method for identifying drug candidate
#559Alzheimer's related proteins and methods of use
#560Method for identifying modulators of NOAH10 useful for treating Alzheimer's disease
#561Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease
#562Method for the Selective Detection of Pathological Protein Depositions
#563Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#564Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
#565Compositions and methods for Alzheimer's disease
#566Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#567Monoclonal antibody
#568Monoclonal antibody
#569Methods compositions and compound assays for inhibiting amyloid-beta protein production
#570Antibody specific for mutant presenilin 2 and method of use thereof
#571Assay Method
#572Amyloid binding assays
#573Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
#574IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES
#575Retromer-based assays and methods for treating alzheimer's disease
#576Inhibition of tau-tau association
#577Genes Associated With Type ll Diabetes Mellitus
#578Method of Assaying Alzheimer's Disease and Diagnostic Reagent
#579Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3
#580Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
#581Anti-addl antibodies and uses thereof
#582Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology
#583Human anti-amyloid β peptide antibody and fragment of said antibody
#584Peptide probes for diagnostics and therapeutics
#585Small molecules for imaging protein-protein interactions
#586Method for Differentiation of Alzheimer's Disease into Subgroups
#587Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
#588COMPOSITIONS AND METHODS FOR DETECTION AND ISOLATION OF PHOSPHORYLATED MOLECULES
#589Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a
#590Monoclonal antibodies and use thereof
#591Remedy for Alzheimer's Disease
#592Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#593ADDL Binding to Hippocampal Neurons
#594Inhibitors of Amyloid Fibril Formation and Uses Thereof
#595Modulator of gamma-secretase
#596Methods And Compositions Comprising Non-Peptide Small Molecules That Solubilize Beta Amyloid Peptide Fiber
#597Methods for treating glaucoma and macular degeneration
#598Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#599Amyloid beta protein channel structure and uses thereof in identifying potential drug molecules for neurodegenerative diseases
#600Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)